Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Coadministration of an interleukin-12 gene and a Trypanosoma cruzi gene improves vaccine efficacy.

Katae M, Miyahira Y, Takeda K, Matsuda H, Yagita H, Okumura K, Takeuchi T, Kamiyama T, Ohwada A, Fukuchi Y, Aoki T.

Infect Immun. 2002 Sep;70(9):4833-40.

3.
5.

Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice.

Gupta S, Garg NJ.

PLoS Negl Trop Dis. 2010 Aug 10;4(8):e797. doi: 10.1371/journal.pntd.0000797.

7.
8.

Co-administration of a plasmid DNA encoding IL-15 improves long-term protection of a genetic vaccine against Trypanosoma cruzi.

Eickhoff CS, Vasconcelos JR, Sullivan NL, Blazevic A, Bruna-Romero O, Rodrigues MM, Hoft DF.

PLoS Negl Trop Dis. 2011 Mar 8;5(3):e983. doi: 10.1371/journal.pntd.0000983.

9.

Genetic immunization based on the ubiquitin-fusion degradation pathway against Trypanosoma cruzi.

Chou B, Hiromatsu K, Hisaeda H, Duan X, Imai T, Murata S, Tanaka K, Himeno K.

Biochem Biophys Res Commun. 2010 Feb 12;392(3):277-82. doi: 10.1016/j.bbrc.2009.12.166. Epub 2010 Jan 7.

PMID:
20059980
10.

Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection.

Haolla FA, Claser C, de Alencar BC, Tzelepis F, de Vasconcelos JR, de Oliveira G, Silvério JC, Machado AV, Lannes-Vieira J, Bruna-Romero O, Gazzinelli RT, dos Santos RR, Soares MB, Rodrigues MM.

Vaccine. 2009 Sep 18;27(41):5644-53. doi: 10.1016/j.vaccine.2009.07.013. Epub 2009 Jul 25.

PMID:
19635607
11.

CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2.

Araújo AF, de Alencar BC, Vasconcelos JR, Hiyane MI, Marinho CR, Penido ML, Boscardin SB, Hoft DF, Gazzinelli RT, Rodrigues MM.

Infect Immun. 2005 Sep;73(9):6017-25.

12.
13.

Protective immunity against trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and trans-sialidase.

Vasconcelos JR, Hiyane MI, Marinho CR, Claser C, Machado AM, Gazzinelli RT, Bruña-Romero O, Alvarez JM, Boscardin SB, Rodrigues MM.

Hum Gene Ther. 2004 Sep;15(9):878-86.

PMID:
15353042
14.

Perforin and gamma interferon expression are required for CD4+ and CD8+ T-cell-dependent protective immunity against a human parasite, Trypanosoma cruzi, elicited by heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccination.

de Alencar BC, Persechini PM, Haolla FA, de Oliveira G, Silverio JC, Lannes-Vieira J, Machado AV, Gazzinelli RT, Bruna-Romero O, Rodrigues MM.

Infect Immun. 2009 Oct;77(10):4383-95. doi: 10.1128/IAI.01459-08. Epub 2009 Aug 3.

15.

Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control Trypanosoma cruzi infection.

Miyahira Y, Takashima Y, Kobayashi S, Matsumoto Y, Takeuchi T, Ohyanagi-Hara M, Yoshida A, Ohwada A, Akiba H, Yagita H, Okumura K, Ogawa H.

Infect Immun. 2005 Nov;73(11):7356-65.

16.

Novel protective antigens expressed by Trypanosoma cruzi amastigotes provide immunity to mice highly susceptible to Chagas' disease.

Silveira EL, Claser C, Haolla FA, Zanella LG, Rodrigues MM.

Clin Vaccine Immunol. 2008 Aug;15(8):1292-300. doi: 10.1128/CVI.00142-08. Epub 2008 Jun 25.

17.

Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells.

Limon-Flores AY, Cervera-Cetina R, Tzec-Arjona JL, Ek-Macias L, Sánchez-Burgos G, Ramirez-Sierra MJ, Cruz-Chan JV, VanWynsberghe NR, Dumonteil E.

Vaccine. 2010 Oct 28;28(46):7414-9. doi: 10.1016/j.vaccine.2010.08.104. Epub 2010 Sep 16.

PMID:
20850536
19.

Critical contribution of immunoproteasomes in the induction of protective immunity against Trypanosoma cruzi in mice vaccinated with a plasmid encoding a CTL epitope fused to green fluorescence protein.

Chou B, Hisaeda H, Shen J, Duan X, Imai T, Tu L, Murata S, Tanaka K, Himeno K.

Microbes Infect. 2008 Mar;10(3):241-50. doi: 10.1016/j.micinf.2007.11.010. Epub 2007 Dec 5.

PMID:
18321749
20.

Cutting edge: a potent adjuvant effect of ligand to receptor activator of NF-kappa B gene for inducing antigen-specific CD8+ T cell response by DNA and viral vector vaccination.

Miyahira Y, Akiba H, Katae M, Kubota K, Kobayashi S, Takeuchi T, García-Sastre A, Fukuchi Y, Okumura K, Yagita H, Aoki T.

J Immunol. 2003 Dec 15;171(12):6344-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk